Health Condition 1: F313- Bipolar disorder, current episodedepressed, mild or moderate severity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Adult aged 18 to 60 years 2 Any gender 3 Diagnosis of bipolar disorder depressive episodes as per ICD 1 1 criteria 4 Currently experiencing a moderate to severe depressive episode as per BDI score more than 19 5 Able to provide informed written consent
Exclusion criteria
Exclusion criteria: 1 History of seizures 2 Presence of metal implants pacemakers or other electronic medical devices 3 Pregnancy or breast feeding mother 4 Substance use disorder except nicotine use 5 Use of other neuro modulator treatment in the present admission 6 With active suicide ideations 7 Uncontrolled co morbidities or any neurological disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate effectiveness and safety of tDCS in bipolar depression improvement as measured by BDI scores Timepoint: baseline, 2 weeks, one month post intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| To monitor and document any adverse effects, including mood switching using YMRS and tDCS side effects checklist (example hypomania or mania) Cognitive functioning and evaluation To measure overall improvement in Quality of life Timepoint: baseline, 2 weeks, one month post intervention | — |
Countries
India
Contacts
Dharwad institute of mental health and neurosciences